Andrew Gabriel Herzog, M.D.,C.M.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 59 | 2021 | 2923 | 6.480 |
Why?
|
| Anticonvulsants | 40 | 2021 | 1854 | 4.880 |
Why?
|
| Menstrual Cycle | 19 | 2022 | 531 | 3.270 |
Why?
|
| Contraception | 6 | 2019 | 317 | 2.900 |
Why?
|
| Progesterone | 21 | 2015 | 737 | 2.640 |
Why?
|
| Seizures | 17 | 2022 | 2583 | 2.100 |
Why?
|
| Contraceptive Agents | 4 | 2017 | 124 | 1.720 |
Why?
|
| Gonadal Steroid Hormones | 10 | 2021 | 687 | 1.610 |
Why?
|
| Sexual Dysfunction, Physiological | 9 | 2010 | 322 | 1.350 |
Why?
|
| Pregnancy, Unplanned | 2 | 2019 | 75 | 1.270 |
Why?
|
| Epilepsy, Temporal Lobe | 16 | 2009 | 377 | 1.190 |
Why?
|
| Epilepsies, Partial | 8 | 2011 | 426 | 1.120 |
Why?
|
| Ovulation | 5 | 2011 | 182 | 0.980 |
Why?
|
| Menstruation Disturbances | 10 | 2009 | 139 | 0.970 |
Why?
|
| Registries | 7 | 2019 | 8090 | 0.950 |
Why?
|
| Epilepsy, Reflex | 1 | 2022 | 20 | 0.900 |
Why?
|
| Folic Acid | 2 | 2019 | 1245 | 0.840 |
Why?
|
| Valproic Acid | 5 | 2016 | 447 | 0.820 |
Why?
|
| Pituitary Diseases | 1 | 2021 | 134 | 0.770 |
Why?
|
| Polycystic Ovary Syndrome | 8 | 2002 | 331 | 0.760 |
Why?
|
| Endocrine System Diseases | 6 | 2007 | 253 | 0.740 |
Why?
|
| Reproduction | 5 | 2007 | 649 | 0.720 |
Why?
|
| Triazines | 5 | 2009 | 310 | 0.680 |
Why?
|
| Hypogonadism | 8 | 2010 | 765 | 0.640 |
Why?
|
| Testosterone | 11 | 2010 | 2359 | 0.630 |
Why?
|
| Vitamin B Complex | 1 | 2019 | 290 | 0.620 |
Why?
|
| Menarche | 2 | 2019 | 488 | 0.610 |
Why?
|
| Contraceptives, Oral, Combined | 2 | 2009 | 109 | 0.600 |
Why?
|
| Contraceptive Agents, Female | 1 | 2017 | 121 | 0.570 |
Why?
|
| Pregnanolone | 2 | 2014 | 61 | 0.560 |
Why?
|
| Contraception Behavior | 1 | 2017 | 170 | 0.550 |
Why?
|
| Epilepsy, Complex Partial | 5 | 2006 | 58 | 0.530 |
Why?
|
| Fertility | 1 | 2019 | 717 | 0.530 |
Why?
|
| Abortion, Spontaneous | 1 | 2019 | 467 | 0.530 |
Why?
|
| Infertility, Female | 2 | 2019 | 756 | 0.520 |
Why?
|
| Luteinizing Hormone | 10 | 2005 | 872 | 0.470 |
Why?
|
| Age of Onset | 2 | 2019 | 3333 | 0.440 |
Why?
|
| Premenstrual Syndrome | 2 | 2011 | 108 | 0.440 |
Why?
|
| Progestins | 3 | 2009 | 287 | 0.440 |
Why?
|
| Alcoholism | 1 | 2022 | 1855 | 0.430 |
Why?
|
| Kindling, Neurologic | 2 | 2002 | 30 | 0.430 |
Why?
|
| Clomiphene | 5 | 1998 | 71 | 0.420 |
Why?
|
| Adolescent | 37 | 2019 | 85001 | 0.420 |
Why?
|
| Circadian Rhythm | 3 | 2015 | 2551 | 0.410 |
Why?
|
| Estradiol | 11 | 2011 | 1984 | 0.400 |
Why?
|
| Adrenal Hyperplasia, Congenital | 2 | 2001 | 101 | 0.380 |
Why?
|
| Female | 87 | 2022 | 377328 | 0.380 |
Why?
|
| Sex Hormone-Binding Globulin | 3 | 2005 | 542 | 0.380 |
Why?
|
| Amygdala | 4 | 2002 | 1273 | 0.370 |
Why?
|
| Adult | 64 | 2019 | 212128 | 0.360 |
Why?
|
| Functional Laterality | 5 | 2009 | 2299 | 0.340 |
Why?
|
| Drug Interactions | 4 | 2017 | 1455 | 0.320 |
Why?
|
| Aromatase Inhibitors | 2 | 2010 | 506 | 0.320 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2007 | 115 | 0.310 |
Why?
|
| Luteal Phase | 4 | 2011 | 147 | 0.310 |
Why?
|
| Estrogens | 5 | 2007 | 1522 | 0.310 |
Why?
|
| Young Adult | 14 | 2019 | 56155 | 0.310 |
Why?
|
| Ethynodiol Diacetate | 1 | 2005 | 5 | 0.290 |
Why?
|
| Humans | 100 | 2022 | 715118 | 0.290 |
Why?
|
| Ketoconazole | 3 | 2001 | 100 | 0.280 |
Why?
|
| Steroids | 2 | 2011 | 886 | 0.280 |
Why?
|
| Testolactone | 2 | 1998 | 7 | 0.280 |
Why?
|
| Gonadotropin-Releasing Hormone | 5 | 2002 | 1189 | 0.280 |
Why?
|
| Contraceptives, Oral, Hormonal | 2 | 2017 | 182 | 0.280 |
Why?
|
| Endocrine Glands | 1 | 2005 | 100 | 0.270 |
Why?
|
| Gonadotropins, Pituitary | 2 | 2003 | 73 | 0.270 |
Why?
|
| Ethinyl Estradiol | 1 | 2005 | 118 | 0.270 |
Why?
|
| Nitriles | 1 | 2010 | 948 | 0.270 |
Why?
|
| Limbic System | 2 | 1999 | 440 | 0.270 |
Why?
|
| Middle Aged | 39 | 2019 | 214868 | 0.260 |
Why?
|
| Androgens | 3 | 2006 | 1234 | 0.260 |
Why?
|
| Triazoles | 1 | 2010 | 922 | 0.250 |
Why?
|
| Phenytoin | 6 | 2006 | 193 | 0.240 |
Why?
|
| Sexual Behavior | 2 | 2021 | 1899 | 0.240 |
Why?
|
| Follicular Phase | 3 | 2011 | 154 | 0.230 |
Why?
|
| Mood Disorders | 2 | 1999 | 1106 | 0.220 |
Why?
|
| Sexual Dysfunctions, Psychological | 2 | 2006 | 167 | 0.220 |
Why?
|
| Carbamazepine | 4 | 2006 | 223 | 0.220 |
Why?
|
| Pregnancy | 8 | 2019 | 27180 | 0.220 |
Why?
|
| Electroencephalography | 12 | 2015 | 5829 | 0.220 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2009 | 662 | 0.220 |
Why?
|
| Osteoporosis | 1 | 2011 | 1562 | 0.210 |
Why?
|
| Endocrine System | 1 | 2002 | 115 | 0.210 |
Why?
|
| Sex Characteristics | 3 | 2007 | 2536 | 0.210 |
Why?
|
| Paraneoplastic Endocrine Syndromes | 1 | 2000 | 31 | 0.210 |
Why?
|
| Hyperprolactinemia | 2 | 2000 | 133 | 0.200 |
Why?
|
| Leiomyomatosis | 1 | 2000 | 73 | 0.190 |
Why?
|
| Migraine Disorders | 3 | 2007 | 1563 | 0.190 |
Why?
|
| Anovulation | 3 | 2011 | 54 | 0.180 |
Why?
|
| Analysis of Variance | 4 | 2015 | 6531 | 0.180 |
Why?
|
| Glucocorticoids | 2 | 1999 | 2109 | 0.180 |
Why?
|
| Genes, fos | 1 | 1998 | 189 | 0.170 |
Why?
|
| Birth Rate | 1 | 2019 | 146 | 0.170 |
Why?
|
| Hydrocortisone | 3 | 2001 | 1737 | 0.170 |
Why?
|
| Locus Coeruleus | 1 | 1998 | 149 | 0.170 |
Why?
|
| Anxiety Disorders | 2 | 1999 | 2587 | 0.160 |
Why?
|
| Hypothalamus | 3 | 2000 | 1064 | 0.160 |
Why?
|
| Neurons | 5 | 2007 | 9419 | 0.160 |
Why?
|
| Muscle Hypotonia | 1 | 1998 | 146 | 0.160 |
Why?
|
| Bromocriptine | 1 | 1997 | 113 | 0.160 |
Why?
|
| Saliva | 1 | 2001 | 789 | 0.150 |
Why?
|
| Cushing Syndrome | 1 | 1998 | 241 | 0.150 |
Why?
|
| Menopause | 3 | 2003 | 1534 | 0.150 |
Why?
|
| Pregnancy Rate | 1 | 2019 | 599 | 0.150 |
Why?
|
| Retrospective Studies | 8 | 2022 | 72253 | 0.150 |
Why?
|
| Menstruation | 3 | 2011 | 288 | 0.150 |
Why?
|
| Aggression | 1 | 2001 | 742 | 0.150 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 1998 | 375 | 0.150 |
Why?
|
| Live Birth | 1 | 2019 | 459 | 0.140 |
Why?
|
| Intrauterine Devices | 1 | 2017 | 113 | 0.140 |
Why?
|
| Risk | 2 | 2019 | 9772 | 0.140 |
Why?
|
| Leiomyoma | 1 | 2000 | 688 | 0.140 |
Why?
|
| Antifungal Agents | 1 | 1999 | 706 | 0.130 |
Why?
|
| Male | 38 | 2021 | 351080 | 0.130 |
Why?
|
| Age Distribution | 2 | 2019 | 2927 | 0.130 |
Why?
|
| Epilepsy, Generalized | 1 | 1995 | 152 | 0.120 |
Why?
|
| Radioimmunoassay | 1 | 2014 | 956 | 0.120 |
Why?
|
| Periodicity | 3 | 2009 | 378 | 0.120 |
Why?
|
| Odds Ratio | 2 | 2017 | 9968 | 0.120 |
Why?
|
| Prospective Studies | 7 | 2021 | 51182 | 0.120 |
Why?
|
| Iatrogenic Disease | 1 | 1996 | 526 | 0.120 |
Why?
|
| Drug Therapy, Combination | 8 | 2010 | 6538 | 0.110 |
Why?
|
| Torticollis | 1 | 1993 | 67 | 0.110 |
Why?
|
| Sex | 1 | 1992 | 62 | 0.110 |
Why?
|
| Comorbidity | 4 | 2019 | 10423 | 0.110 |
Why?
|
| Prolactin | 2 | 1992 | 674 | 0.110 |
Why?
|
| Neuropeptides | 1 | 1998 | 933 | 0.110 |
Why?
|
| Neuroendocrinology | 1 | 2011 | 6 | 0.110 |
Why?
|
| Neural Inhibition | 2 | 2008 | 593 | 0.110 |
Why?
|
| Dehydroepiandrosterone | 3 | 2006 | 246 | 0.110 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2015 | 761 | 0.100 |
Why?
|
| Erectile Dysfunction | 3 | 1995 | 448 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2015 | 11284 | 0.100 |
Why?
|
| Brain | 7 | 2011 | 25188 | 0.100 |
Why?
|
| Enzyme Inhibitors | 2 | 2003 | 3933 | 0.100 |
Why?
|
| Uterine Neoplasms | 1 | 2000 | 1484 | 0.100 |
Why?
|
| Affect | 1 | 1999 | 1503 | 0.100 |
Why?
|
| Age Factors | 5 | 2017 | 18789 | 0.100 |
Why?
|
| Income | 1 | 2019 | 1800 | 0.100 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 23281 | 0.090 |
Why?
|
| Migraine with Aura | 1 | 2011 | 199 | 0.090 |
Why?
|
| Ovariectomy | 1 | 2011 | 655 | 0.090 |
Why?
|
| Statistics, Nonparametric | 2 | 2007 | 2936 | 0.090 |
Why?
|
| Treatment Outcome | 8 | 2015 | 62186 | 0.090 |
Why?
|
| Pregnancy Complications | 3 | 2017 | 2827 | 0.090 |
Why?
|
| Injections, Intramuscular | 1 | 2010 | 562 | 0.090 |
Why?
|
| Cerebrum | 1 | 2009 | 126 | 0.080 |
Why?
|
| Double-Blind Method | 3 | 2012 | 11900 | 0.080 |
Why?
|
| Hormone Replacement Therapy | 2 | 2006 | 740 | 0.080 |
Why?
|
| Androstanes | 1 | 2006 | 21 | 0.080 |
Why?
|
| Neurosecretory Systems | 1 | 1989 | 238 | 0.080 |
Why?
|
| Gonadal Disorders | 1 | 2006 | 7 | 0.080 |
Why?
|
| Insurance, Health | 1 | 2019 | 2496 | 0.070 |
Why?
|
| Quality of Life | 1 | 2007 | 11691 | 0.070 |
Why?
|
| Enzyme Induction | 1 | 2006 | 516 | 0.070 |
Why?
|
| Severity of Illness Index | 4 | 2011 | 16011 | 0.070 |
Why?
|
| United States | 4 | 2019 | 67666 | 0.070 |
Why?
|
| Biological Availability | 1 | 2006 | 403 | 0.070 |
Why?
|
| Sickness Impact Profile | 1 | 2007 | 318 | 0.070 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2006 | 150 | 0.070 |
Why?
|
| Malformations of Cortical Development | 1 | 2008 | 209 | 0.070 |
Why?
|
| Cerebral Cortex | 4 | 2008 | 5718 | 0.070 |
Why?
|
| Biological Clocks | 1 | 2008 | 331 | 0.070 |
Why?
|
| Menorrhagia | 1 | 2005 | 57 | 0.070 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2006 | 255 | 0.070 |
Why?
|
| Transcranial Magnetic Stimulation | 2 | 2005 | 1307 | 0.070 |
Why?
|
| Central Nervous System Diseases | 1 | 1989 | 531 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2002 | 8602 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2017 | 3078 | 0.070 |
Why?
|
| Logistic Models | 2 | 2019 | 13594 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3565 | 0.070 |
Why?
|
| Reference Values | 3 | 2001 | 5061 | 0.060 |
Why?
|
| Electrophysiology | 1 | 2007 | 1331 | 0.060 |
Why?
|
| Personality Inventory | 1 | 2007 | 1055 | 0.060 |
Why?
|
| Internet | 1 | 2017 | 3078 | 0.060 |
Why?
|
| Hypothalamus, Middle | 1 | 2002 | 29 | 0.060 |
Why?
|
| Rats | 5 | 2002 | 25090 | 0.060 |
Why?
|
| Drug Combinations | 2 | 2006 | 1941 | 0.060 |
Why?
|
| Forecasting | 2 | 2011 | 2944 | 0.060 |
Why?
|
| Abdominal Pain | 1 | 1989 | 1028 | 0.060 |
Why?
|
| Electric Stimulation | 2 | 2005 | 1778 | 0.060 |
Why?
|
| Kainic Acid | 1 | 2002 | 205 | 0.060 |
Why?
|
| Finasteride | 1 | 2003 | 88 | 0.060 |
Why?
|
| Drug Administration Schedule | 3 | 2001 | 5039 | 0.060 |
Why?
|
| Immunohistochemistry | 3 | 2002 | 11766 | 0.060 |
Why?
|
| Infertility | 1 | 2007 | 573 | 0.050 |
Why?
|
| Women's Health | 2 | 2001 | 1934 | 0.050 |
Why?
|
| Statistics as Topic | 1 | 2008 | 2406 | 0.050 |
Why?
|
| Laparoscopy | 1 | 2011 | 1990 | 0.050 |
Why?
|
| Administration, Intravaginal | 2 | 1993 | 143 | 0.050 |
Why?
|
| Animals | 9 | 2009 | 170733 | 0.050 |
Why?
|
| Dehydroepiandrosterone Sulfate | 2 | 1999 | 242 | 0.050 |
Why?
|
| Antidepressive Agents | 2 | 2006 | 2836 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2021 | 39804 | 0.050 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2006 | 1182 | 0.050 |
Why?
|
| Health Occupations | 1 | 2000 | 218 | 0.040 |
Why?
|
| Aging | 3 | 2005 | 8368 | 0.040 |
Why?
|
| Sleep | 2 | 2008 | 4210 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 8016 | 0.040 |
Why?
|
| Bone Density | 1 | 2011 | 3411 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2005 | 3091 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2007 | 6480 | 0.040 |
Why?
|
| Substantia Nigra | 1 | 1998 | 359 | 0.040 |
Why?
|
| Time Factors | 4 | 2015 | 41082 | 0.040 |
Why?
|
| Ovarian Cysts | 2 | 1988 | 114 | 0.040 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1998 | 632 | 0.040 |
Why?
|
| Dementia | 3 | 1999 | 2254 | 0.040 |
Why?
|
| Contraceptives, Oral | 2 | 2000 | 555 | 0.030 |
Why?
|
| Receptors, GABA-A | 1 | 1999 | 623 | 0.030 |
Why?
|
| Sex Factors | 3 | 1999 | 10651 | 0.030 |
Why?
|
| Depression | 2 | 2007 | 7256 | 0.030 |
Why?
|
| Follicle Stimulating Hormone | 2 | 1986 | 730 | 0.030 |
Why?
|
| Electromyography | 1 | 1998 | 1379 | 0.030 |
Why?
|
| Prednisone | 1 | 1998 | 1549 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2000 | 1279 | 0.030 |
Why?
|
| Paraneoplastic Syndromes | 1 | 1994 | 154 | 0.030 |
Why?
|
| Uterine Cervical Diseases | 1 | 1993 | 78 | 0.030 |
Why?
|
| Amnesia | 1 | 1994 | 241 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14877 | 0.030 |
Why?
|
| Amenorrhea | 1 | 1996 | 486 | 0.030 |
Why?
|
| Salpingectomy | 1 | 2011 | 53 | 0.030 |
Why?
|
| Motor Neuron Disease | 1 | 1992 | 109 | 0.030 |
Why?
|
| Libido | 1 | 1992 | 117 | 0.030 |
Why?
|
| Hormones | 1 | 1995 | 858 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 15258 | 0.030 |
Why?
|
| Temporal Lobe | 1 | 1999 | 1659 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2009 | 12488 | 0.030 |
Why?
|
| Menopause, Premature | 1 | 2011 | 126 | 0.020 |
Why?
|
| Models, Biological | 1 | 2007 | 9893 | 0.020 |
Why?
|
| Tumor Virus Infections | 1 | 1993 | 457 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2000 | 2333 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 1990 | 334 | 0.020 |
Why?
|
| Gonadotropins | 1 | 1990 | 237 | 0.020 |
Why?
|
| Muscle Cramp | 1 | 1988 | 35 | 0.020 |
Why?
|
| Pituitary Hormone-Releasing Hormones | 1 | 1988 | 43 | 0.020 |
Why?
|
| Testicular Neoplasms | 1 | 1994 | 762 | 0.020 |
Why?
|
| Neural Pathways | 1 | 1998 | 3023 | 0.020 |
Why?
|
| Testis | 1 | 1990 | 811 | 0.020 |
Why?
|
| Nausea | 1 | 1989 | 658 | 0.020 |
Why?
|
| Mastectomy, Segmental | 1 | 1992 | 945 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2001 | 9022 | 0.020 |
Why?
|
| Papillomaviridae | 1 | 1993 | 1144 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2000 | 3894 | 0.020 |
Why?
|
| Prevalence | 2 | 2001 | 14869 | 0.020 |
Why?
|
| Hysterectomy | 1 | 2011 | 904 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2000 | 3950 | 0.020 |
Why?
|
| Climacteric | 1 | 2004 | 57 | 0.020 |
Why?
|
| Radiotherapy | 1 | 1992 | 1623 | 0.020 |
Why?
|
| Neuropsychological Tests | 2 | 1999 | 6922 | 0.020 |
Why?
|
| Pelvis | 1 | 1988 | 693 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 1998 | 13267 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 18345 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2000 | 7480 | 0.010 |
Why?
|
| Reproductive History | 1 | 2003 | 207 | 0.010 |
Why?
|
| Diarrhea | 1 | 1989 | 1369 | 0.010 |
Why?
|
| Population Surveillance | 1 | 1993 | 2631 | 0.010 |
Why?
|
| Cognition | 1 | 1999 | 6081 | 0.010 |
Why?
|
| Placebos | 1 | 2006 | 1733 | 0.010 |
Why?
|
| Papillomavirus Infections | 1 | 1993 | 1510 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1993 | 1972 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 1999 | 39285 | 0.010 |
Why?
|
| Breast | 1 | 1988 | 1818 | 0.010 |
Why?
|
| Pain | 2 | 1988 | 4662 | 0.010 |
Why?
|
| Ovary | 1 | 2003 | 1003 | 0.010 |
Why?
|
| Wechsler Scales | 1 | 1999 | 268 | 0.010 |
Why?
|
| Mental Status Schedule | 1 | 1999 | 316 | 0.010 |
Why?
|
| Postmenopause | 1 | 2006 | 2420 | 0.010 |
Why?
|
| Irritable Mood | 1 | 1998 | 176 | 0.010 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 1998 | 442 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 1980 | 789 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 2000 | 697 | 0.010 |
Why?
|
| Sleep, REM | 1 | 1999 | 586 | 0.010 |
Why?
|
| Smoking | 1 | 1993 | 8932 | 0.010 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 1998 | 515 | 0.010 |
Why?
|
| Needs Assessment | 1 | 2000 | 1149 | 0.010 |
Why?
|
| Abdomen | 1 | 1978 | 1101 | 0.010 |
Why?
|
| Serotyping | 1 | 1993 | 378 | 0.010 |
Why?
|
| Polysomnography | 1 | 1999 | 1747 | 0.010 |
Why?
|
| Rib Fractures | 1 | 1992 | 109 | 0.010 |
Why?
|
| Pericarditis | 1 | 1992 | 115 | 0.010 |
Why?
|
| Bucladesine | 1 | 1990 | 128 | 0.010 |
Why?
|
| Leydig Cells | 1 | 1990 | 57 | 0.010 |
Why?
|
| Hydroxylation | 1 | 1990 | 136 | 0.010 |
Why?
|
| Mice | 1 | 1998 | 80997 | 0.010 |
Why?
|
| Brachial Plexus | 1 | 1992 | 168 | 0.010 |
Why?
|
| Serotonin Uptake Inhibitors | 1 | 1998 | 1428 | 0.010 |
Why?
|
| Vaginal Smears | 1 | 1993 | 500 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 2268 | 0.010 |
Why?
|
| Aged | 5 | 2003 | 162672 | 0.010 |
Why?
|
| Antigens | 1 | 1994 | 1511 | 0.010 |
Why?
|
| Survivors | 1 | 1999 | 2165 | 0.010 |
Why?
|
| Chorionic Gonadotropin | 1 | 1990 | 458 | 0.010 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1990 | 433 | 0.010 |
Why?
|
| Necrosis | 1 | 1992 | 1650 | 0.010 |
Why?
|
| Curriculum | 1 | 2000 | 3398 | 0.010 |
Why?
|
| Neck | 1 | 1992 | 707 | 0.000 |
Why?
|
| Carcinoma in Situ | 1 | 1993 | 820 | 0.000 |
Why?
|
| Recurrence | 1 | 1998 | 8269 | 0.000 |
Why?
|
| Blotting, Western | 1 | 1994 | 5441 | 0.000 |
Why?
|
| Lymph Node Excision | 1 | 1992 | 1198 | 0.000 |
Why?
|
| Autoantibodies | 1 | 1994 | 1993 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 2003 | 21789 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1992 | 20058 | 0.000 |
Why?
|
| Urban Population | 1 | 1993 | 2026 | 0.000 |
Why?
|
| Neoplasms, Second Primary | 1 | 1992 | 1008 | 0.000 |
Why?
|
| Radiation Injuries | 1 | 1992 | 1226 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 1999 | 13573 | 0.000 |
Why?
|
| Health Surveys | 1 | 1993 | 4021 | 0.000 |
Why?
|
| Risk Factors | 2 | 2002 | 70705 | 0.000 |
Why?
|
| Aged, 80 and over | 2 | 1999 | 58503 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1992 | 8912 | 0.000 |
Why?
|
| Phosphorylation | 1 | 1990 | 8738 | 0.000 |
Why?
|
| Remission, Spontaneous | 1 | 1978 | 390 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 34394 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1993 | 4028 | 0.000 |
Why?
|
| Mass Screening | 1 | 1993 | 5204 | 0.000 |
Why?
|
| Alzheimer Disease | 1 | 1992 | 7224 | 0.000 |
Why?
|
| Child | 1 | 1998 | 74147 | 0.000 |
Why?
|